A drug used to treat feline infectious peritonitis, an often fatal coronavirus infection in cats, may hold the key for developing a treatment for human COVID-19.
As many as two in five Americans report concerns about experiencing increased anxiety in the wake of coronavirus. 68% of people feel like everything is out of their control. 38% of Americans report feeling optimistic about the country's recovery, believing we will come out of the pandemic stronger than before.
AI model determined three key features that accurately predict subsequent, severe disease in COVID-19 patients. The three features were levels of the liver enzyme ALT, reported myalgia, and hemoglobin levels. Based on these three factors, the AI was able to determine ARDS risk with 80% accuracy.
Researchers have identified the structural basis for SARS-CoV-2 inhibition by the drug Remdesivir. The findings reveal a potential binding pattern that offers support for the design of new, more efficient, and specific anti-COVID-19 drugs.
Reviewing data from past pandemics, researchers suggest some of those exposed to COVID-19 could have an increased risk of developing neurological and mental health disorders in the long term. Acute viral infections can result in encephalopathy, psychosis, depression, demyelination disorders, and problems with neuromuscular function.
Treating coronavirus patients with alpha-blockers may help prevent the cytokine storm associated with severe COVID-19 infection. Alpha-blockers interfere with the cell signaling that triggers cytokine storms. Mice with bacterial infections that were treated with alpha-blockers experienced reduced cytokine storms and decreased death rates.
SARS-CoV-2, the virus responsible for COVID-19, can linger for days in sewage and water systems and remain infectious. Researchers call for new studies to determine if current water treatment methods are efficient and effective at killing SARS-CoV-2.
Study investigates whether overactive immune cells that produce neutrophil extracellular traps (NETs) are responsible for more severe and lethal cases of coronavirus.
Researchers are developing new ultraviolet LEDs that can clean surfaces contaminated with COVID-19. The LEDs will also be able to purify air and water that contain coronavirus.
Johns Hopkins University researchers propose using antibodies from the plasma or serum of those who have recovered from COVID-19 to help boost the immunity of newly infected patients and for those at risk of contracting the disease. Researchers say the antibodies may bind to and neutralize SARS-CoV-2. The technique has been proven successful in prior outbreaks, including the SARS epidemic and the 1918 flu pandemic.
University of Melbourne researchers are conducting trials to see if intravenous administration of zinc chloride will help combat some of the effects of COVID-19. Previous studies have shown zinc is effective at slowing the rate of other respiratory infections, such as SARS.